These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 11999571)
41. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications. Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D Blood; 1997 Mar; 89(5):1838-9. PubMed ID: 9057674 [No Abstract] [Full Text] [Related]
42. The role of cladribine in the treatment of lymphoid malignancies. Nelson MC; Hogan DK Oncol Nurs Forum; 1995 Oct; 22(9):1395-400. PubMed ID: 8539180 [TBL] [Abstract][Full Text] [Related]
43. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications. Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389 [TBL] [Abstract][Full Text] [Related]
44. Gynecomastia in a case of hairy cell leukaemia--cladribine induced? Abhyankar D; Saikia T; Advani S Leuk Lymphoma; 2001 Jun; 42(1-2):243-6. PubMed ID: 11699216 [TBL] [Abstract][Full Text] [Related]
45. Cladribine: from the bench to the bedside--focus on hairy cell leukemia. Greyz N; Saven A Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311 [TBL] [Abstract][Full Text] [Related]
46. Criteria for use of cladribine in adults. Fedak MN Am J Hosp Pharm; 1994 Sep; 51(17):2185-6. PubMed ID: 7985700 [No Abstract] [Full Text] [Related]
47. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia. Else M; Osuji N; Forconi F; Dearden C; Del Giudice I; Matutes E; Wotherspoon A; Lauria F; Catovsky D Cancer; 2007 Nov; 110(10):2240-7. PubMed ID: 17886250 [TBL] [Abstract][Full Text] [Related]
48. Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Zinzani PL; Magagnoli M; Bendandi M; Tani M; Stefoni V; Cellini C; Poggi S; Piccioli M; Pileri S; Tura S Haematologica; 2000 Sep; 85(9):922-5. PubMed ID: 10980629 [TBL] [Abstract][Full Text] [Related]
49. Cladribine in hairy cell leukemia. Belani R; Saven A Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111 [TBL] [Abstract][Full Text] [Related]
50. High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing. Meher-Homji Z; Tam CS; Siderov J; Seymour JF; Holmes NE; Chua KYL; Phillips EJ; Slavin MA; Trubiano JA Leuk Lymphoma; 2019 Dec; 60(14):3455-3460. PubMed ID: 31256738 [TBL] [Abstract][Full Text] [Related]
51. Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosis. Hilbe W; Berger T; Konwalinka G; Thaler J Acta Haematol; 1999; 102(2):99-100. PubMed ID: 10529514 [TBL] [Abstract][Full Text] [Related]
52. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine]. Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752 [TBL] [Abstract][Full Text] [Related]
53. Development of cladribine at Scripps for hairy cell leukemia and current results. Torrey ML; Sigal DS; Saven A Leuk Lymphoma; 2011 Jun; 52 Suppl 2():29-33. PubMed ID: 21504293 [TBL] [Abstract][Full Text] [Related]
54. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA). Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521 [TBL] [Abstract][Full Text] [Related]
55. [Hypersensitivity reactions to multiple drugs during the course of hairy cell leukemia treated with 2-chlorodeoxyadenosine]. Kokunai A; Azusawa H; Murota H; Ohhata C; Katayama I; Murata S; Tadokoro S Arerugi; 2006 Jun; 55(6):662-6. PubMed ID: 16883103 [TBL] [Abstract][Full Text] [Related]